9th Annual Biomarkers Congress

Immunology: Harvard University

Total Score People Score Events Score
105 92 27
Date Event Presentation Speakers
April 28, 2014 Companion Diagnostics: From Biomarker Identification to Market Entry Genomics Medicine Raju Kucherlapati
February 17, 2014 Sao Paulo Advanced School in Oncogenesis and Translational Medicine (ESPCA) + Bioinformatics (Mini-course) Molecular-based classification of glioblastoma – Prof. Dr. Cameron Brennan Cameron W Brennan
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Systems Biological Approaches to Vaccination Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Ofer Levy
Poster Viewing Ofer Levy
Immunology of Vaccination in the Young and Elderly Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Ofer Levy
September 15, 2013 2nd International Conference on ImmunoMetabolism: Molecular and Cellular Immunology of Metabolism Session IV Immune Cell Effectors – Pt. 2 Filip K. Swirski
Session IV Immune Cell Effectors – Pt. 2 Filip K. Swirski
Session VI Hot Topics Gokhan Hotamisligil,
Session VIII Translational Medicine Steven Shoelson
Session VIII Translational Medicine Steve Shoelson
July 17, 2013 16th International Congress of Mucosal Immunology (ICMI 2013) State of the Art - Tsuchiya Memorial Lecture Ramnik J. Xavier
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
July 10, 2011 Nutritional Immunology: Role in Health and Disease Obesity, insulin resistance and innate immunity Steven Shoelson
Session 2 | Obesity Induced Immune Dysfunction Steven Shoelson
Vitamin A and immune regulation Jorge Rodrigo Mora
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) Mucosal Biology (X5) | Protein Domains, Signaling Networks, and Immunity Ramnik J. Xavier
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Innovative Approaches in Modern Medicine and Vaccine Development | Protein Domains, Signaling Networks, and Immunity Ramnik J. Xavier
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Mechanisms of Protective Tumor Immunity Glenn Dranoff
January 13, 2011 Immunology and metabolism SESSION II IMMUNOLOGY AND LIPIDS: IMPACT ON CLINICS Christopher GLASS
SESSION IV : METABOLIC MODULATION OF IMMUNE RESPONSES Diane Mathis
The sterile inflammatory response Kenneth Rock
Nuclear receptor signaling pathways at the intersection of inflammation and metabolism Christopher GLASS
Control of metabolic processes by the adaptive immune system Diane Mathis
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Genetic and Pharmacological Interventions to Treat Age-related Diseases | Columbine Ballroom David A Sinclair
Systems Analysis of Mitochondrial Function | Columbine Ballroom Vamsi K Mootha
Transcriptional Regulation of Adipogenesis and Energy Homeostasis | Columbine Ballroom Bruce Spiegelman
Insulin Resistance, Mitochondrial Dysfunction and Lipotoxicity in Humans | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
Panel: Mechanisms of Insulin Resistance: Recent Advances and Current Controversies (Joint) | Columbine Ballroom Barbara Kahn
January 12, 2011 Obesity (J2) Genetic and Pharmacological Interventions to Treat Age-related Diseases | Columbine Ballroom David A Sinclair
Systems Analysis of Mitochondrial Function | Columbine Ballroom Vamsi K Mootha
Transcriptional Regulation of Adipogenesis and Energy Homeostasis | Columbine Ballroom Bruce Spiegelman
Diabetes (J1) | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
January 9, 2011 NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses (A4) NKT Cell Activation by Fungi and Bacteria | Colorado Ballroom Michael Brenner
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Diane Mathis
September 25, 2010 The Management of Women with Chronic Immune Disorders in the Era of Biologics Q&A with panel discussion: Maintaining health and quality of life Sonia Friedman, Alexa Boer Kimball
Quality of life and social connectivity for women: A comparison across immune disorders Alexa Boer Kimball
Healthcare maintenance for immune disorders: An update on vaccinations, bone monitoring, and cancer screening Sonia Friedman
Q&A with panel discussion: Are children just little adults? Daniela Kroshinsky
The Young and the Restless: A case-based approach to growth, medication risk, and transition of care Daniela Kroshinsky
Summary and concluding remarks Alexa Boer Kimball
Q&A with Panel discussion: Managing patient’s expectations on pregnancy Sonia Friedman
August 18, 2010 Novel Vaccines: Adjuvants & Delivery Systems Adjuvantation of a Vaccine without Adjuvant Injection Mei X. Wu
April 11, 2010 Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2) * Multigene Families: Role in Immunity and Pathology | Big Horn B Peter R. Preiser
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Agonists of Pattern Recognition Receptors, including TLRs and NLRs, as Vaccine Adjuvants: Current Practice and Translational Development Ofer Levy
DNA Vaccines for HIV-1 Dan H Barouch
July 9, 2009 "The 5th RCAI-JSI International Symposium on Immunology 2009 ""Cellular and Genetic View on Autoimmunity" Presentation 2 Diane Mathis
Presentation 5 Christophe Benoist
Presentation 4 Vijay Kuchroo
Presentation 2 David A. Hafler
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
August 18, 2008 Systems Integration in Biodefense Leveraging Cell Phone Technology to Make Point-of-Care Diagnostics Accessible in the Developing World Boris Nikolic
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE New directions in adipocyte development Evan Rosen
February 3, 2008 TGF-ß Family in Homeostasis and Disease Registration Test User
Signaling System I Alexander F. Schier, Lan Xu
Cancer II Nabeel H Bardeesy
September 25, 2007 Toll-like receptors - Investigating innate immunity & infection Morning Tea/Coffee and Poster Viewing Gerhard Wagner
July 28, 2007 Nutritional Immunology: Its Role in Health and Disease Cholesterol-sensitive signaling pathways in cancer Michael R Freeman
Probiotics and gut associated immune response Allen Walker
Micronutrient modulation of the progression of HIV infection in adults and children Saurabh Mehta
Dietary enhancement of human gamma delta T cell function with a defined mixture of green tea molecules correlates with prevention of cold and flu symptoms Jake Bukowski
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.